Cargando…

Effects of Intravenous Landiolol on Heart Rate and Outcomes in Patients with Atrial Tachyarrhythmias and Acute Decompensated Heart Failure: A Single-Center Experience

OBJECTIVE: Atrial tachyarrhythmias (ATAs) lead to clinical deterioration and worsening heart failure (HF) in patients with acute decompensated HF (ADHF). We evaluated the effects of the ultrashort-acting intravenous β1-blocker landiolol on the heart rate, hemodynamics, and outcome in patients with A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsui, Yuko, Suzuki, Atsushi, Shiga, Tsuyoshi, Arai, Kotaro, Hagiwara, Nobuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423156/ https://www.ncbi.nlm.nih.gov/pubmed/30810944 http://dx.doi.org/10.1007/s40801-019-0149-1

Ejemplares similares

Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure
por: Shiga, Tsuyoshi
Publicado: (2022)

Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
por: Kikuchi, Noriko, et al.
Publicado: (2020)

Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia
por: Kiuchi, Shunsuke, et al.
Publicado: (2017)

Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series
por: Ditali, Valentina, et al.
Publicado: (2021)

Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range Ejection Fraction: A Prospective Observational Study
por: Tsukamoto, Kei, et al.
Publicado: (2020)

The role of landiolol in the management of atrial tachyarrhythmias in patients with acute heart failure and cardiogenic shock: case reports and review of literature
por: Bezati, Sofia, et al.
Publicado: (2022)

Deactivation of implantable cardioverter defibrillator in Japanese patients with end‐stage heart failure
por: Nakazawa, Mayui, et al.
Publicado: (2020)

Urgent Control of Rapid Atrial Fibrillation by Landiolol in Patients With Acute Decompensated Heart Failure With Severely Reduced Ejection Fraction
por: Iwahashi, Noriaki, et al.
Publicado: (2019)

Switching Therapy from Intravenous Landiolol to Transdermal Bisoprolol in a Patient with Thyroid Storm Complicated by Decompensated Heart Failure and Gastrointestinal Dysfunction
por: Godo, Shigeo, et al.
Publicado: (2017)

Efficacy and Safety of Landiolol in Patients With Ventricular Tachyarrhythmias With or Without Renal Impairment　― Subanalysis of the J-Land II Study ―
por: Shiga, Tsuyoshi, et al.
Publicado: (2020)

Safety and Efficacy of Landiolol Hydrochloride in Children with Tachyarrhythmia of Various Etiologies
por: Ashida, Atsuko, et al.
Publicado: (2021)

Landiolol for refractory tachyarrhythmias in the intensive care unit: case reports
por: Gangl, Clemens, et al.
Publicado: (2022)

Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure
por: Nomoto, Michiru, et al.
Publicado: (2022)

Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data
por: Hirai, Toshinori, et al.
Publicado: (2022)

Incidence and predictors of early and late sudden cardiac death in hospitalized Japanese patients with new‐onset systolic heart failure
por: Minami, Yoshiaki, et al.
Publicado: (2021)

Patient Health Questionnaire-2 Screening for Depressive Symptoms in Japanese Outpatients with Heart Failure
por: Suzuki, Tsuyoshi, et al.
Publicado: (2019)

Adverse Drug Reactions in Japanese Patients with End-Stage Heart Failure Receiving Continuous Morphine Infusion: A Single-Center Retrospective Cohort Study
por: Gotou, Masayuki, et al.
Publicado: (2021)

Atrial tachyarrhythmia in adult congenital heart disease
por: Karbassi, Arsha, et al.
Publicado: (2017)

Mid-Term Prognosis After Landiolol Treatment in Atrial Fibrillation/Atrial Flutter Patients With Chronic Heart Failure　― A Prospective Observational Survey (AF-CHF Landiolol Survey) ―
por: Yamashita, Takeshi, et al.
Publicado: (2020)

Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
por: Wada, Yuko, et al.
Publicado: (2016)

Decompensated heart failure
por: Mangini, Sandrigo, et al.
Publicado: (2013)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Effectiveness and safety of dabigatran versus warfarin in “real-world” Japanese patients with atrial fibrillation: A single-center observational study
por: Naganuma, Miyoko, et al.
Publicado: (2017)

Mapping strategy for multiple atrial tachyarrhythmias in a transplant heart
por: Jin, Qi, et al.
Publicado: (2015)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
por: Ahmed, Fozia Z., et al.
Publicado: (2021)

Heart failure and atrial fibrillation: tachycardia‐mediated acute decompensation
por: Park, Jin Joo, et al.
Publicado: (2021)

Frequency of Atrial Fibrillation in Patients Presenting With Decompensated Heart Failure
por: Ullah, Rafi, et al.
Publicado: (2021)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Foreword: Acute optimization of heart rate in atrial fibrillation: landiolol as a first line therapy
por: Dan, Gheorghe-Andrei
Publicado: (2022)

Efficacy and safety of digoxin in acute heart failure triggered by tachyarrhythmia
por: Shrestha, Samyut, et al.
Publicado: (2022)

Iatrogenic Decompensated Heart Failure
por: Tran, Patrick, et al.
Publicado: (2020)

Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study
por: Shiga, Tsuyoshi, et al.
Publicado: (2015)

Intravenous furosemide in decompensated heart failure: do not protocolize dosing but the desired effect!
por: de Grooth, Harm-Jan S, et al.
Publicado: (2014)

Echocardiographic predictors of change in renal function with intravenous diuresis for decompensated heart failure
por: Gannon, Stephen A., et al.
Publicado: (2018)

Clinical Outcomes of Direct Oral Anticoagulants and Warfarin in Japanese Patients with Atrial Fibrillation Aged ≥ 85 Years: A Single-Center Observational Study
por: Naganuma, Miyoko, et al.
Publicado: (2020)

Atrial Fibrillation in Decompensated Heart Failure: Associated Factors and In-Hospital Outcome
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2014)

A Case of Multifaceted Assessment in an Elderly Patient With Acute Decompensated Heart Failure
por: Sako, Hideto, et al.
Publicado: (2017)

Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Efficacy and safety of cardioversion with continuous landiolol infusion for atrial tachyarrhythmia in an inflammatory state caused by volvulus in a child with TARP syndrome and postoperative tetralogy of Fallot
por: Miyamoto, Kenji, et al.
Publicado: (2018)

Premature ventricular contraction increases the risk of heart failure and ventricular tachyarrhythmia
por: Kim, Yun Gi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nvvu43k7llenech69eumjcno8a